How treatment partners help: social analysis of an African adherence support intervention

Kelli N O'Laughlin, Monique A Wyatt, Sylvia Kaaya, David R Bangsberg, Norma C Ware, Kelli N O'Laughlin, Monique A Wyatt, Sylvia Kaaya, David R Bangsberg, Norma C Ware

Abstract

Treatment partnering is an adherence intervention developed in sub-Saharan Africa. This paper describes the additional social functions that treatment partners serve and shows how these functions contribute to health and survival for patients with HIV/AIDS. Ninety-eight minimally structured interviews were conducted with twenty pairs of adult HIV/AIDS patients (N = 20) and treatment partners (N = 20) treated at a public HIV-care setting in Tanzania. Four social functions were identified using inductive, category construction and interpretive methods of analysis: (1) encouraging disclosure; (2) combating stigma; (3) restoring hope; and (4) reducing social difference. These functions work to restore social connections and reverse the isolating effects of HIV/AIDS, strengthening access to essential community safety nets. Besides encouraging ARV adherence, treatment partners contribute to the social health of patients. Social health as well as HIV treatment success is essential to survival for persons living with HIV/AIDS in sub-Saharan Africa.

References

    1. Binagwaho A, Ratnayake N. The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med. 2009;6(1):e18. doi: 10.1371/journal.pmed.1000018.
    1. Wilkinson-Maposa S, Fowler A, Oliver-Evans C, Mulenga CFN. The poor Philanthropist: how and why the poor help each other. Capetown: University of Capetown School of Business; 2006.
    1. Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007;101(1):79–84. doi: 10.1016/j.trstmh.2006.05.010.
    1. McInerney PA, Ncama BP, Wantland D, Bhengu BR, McGibbon C, Davis SM, et al. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci. 2008;10(4):266–272. doi: 10.1111/j.1442-2018.2008.00410.x.
    1. Demeester Rm, Omes C, Karasi JC, Schneider S, Mugabo J, Maliboli MJ, et al. Adherence to first-line antiretroviral regimens in Rwanda. J Acquir Immune Defic Syndr. 2005;40(1):113–114. doi: 10.1097/01.qai.0000176590.68430.59.
    1. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients’ adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J. 2008;5(3):136–143. doi: 10.1080/17290376.2008.9724912.
    1. Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, et al. “It’s all the time in my mind”: facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med. 2009;68(10):1793–1800. doi: 10.1016/j.socscimed.2009.02.037.
    1. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11. doi: 10.1371/journal.pmed.1000011.
    1. Farmer P, Léandre F, Mukherjee J, Gupta R, Tarter L, Kim JY. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy) Bull World Health Organ. 2001;79(12):1145–1151.
    1. Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S134–S141.
    1. Sarna A, Luchters S, Geibel S, Chersich MF, Munyao P, Kaai S, et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. J Acquir Immune Defic Syndr. 2008;48(5):611–619. doi: 10.1097/QAI.0b013e3181806bf1.
    1. Bradley-Ewing A, Thomson D, Pinkston M, Goggin KJ. A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence. AIDS Patient Care STDS. 2008;22(8):663–668. doi: 10.1089/apc.2007.0190.
    1. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S123–S126.
    1. Mukherjee JS, Eustache FE. Community health workers as a cornerstone for integrating HIV and primary healthcare. AIDS Care. 2007;19(Suppl 1):S73–S82. doi: 10.1080/09540120601114485.
    1. Behforouz HÂ L, Farmer PÂ E, Mukherjee JÂ S. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis. 2004;38(S5):S429–S436. doi: 10.1086/421408.
    1. Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010;5(6):e10923. doi: 10.1371/journal.pone.0010923.
    1. Torpey KE, Kabaso ME, Mutale LN, Kamanga MK, Mwango AJ, Simpungwe J, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3(5):e2204. doi: 10.1371/journal.pone.0002204.
    1. Apondi RBA, Bunnell RS, Awor AM, Wamai NMMPH, Bikaako-Kajura WM, Solberg PMD, et al. Home-based antiretroviral care Is associated with positive social outcomes in a prospective Cohort in Uganda. J Acquir Immune Defic Syndr. 2007;44(1):71–76. doi: 10.1097/01.qai.0000243113.29412.dd.
    1. Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006;368(9547):1587–1594. doi: 10.1016/S0140-6736(06)69118-6.
    1. Taiwo BO, Idoko JA, Welty LJ, Otoh I, Job G, Iyaji PG, et al. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;54(1):85–92. doi: 10.1097/01.qai.0000371678.25873.1c.
    1. Taiwo BO, Idoko JA, Marcelin AG, Otoh I, Reddy S, Iyaji PG, et al. Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial. J Acquir Immune Defic Syndr. 2010;54(5):563–565. doi: 10.1097/QAI.0b013e3181e5112f.
    1. Nachega JB, Chaisson RE, Goliath R, Efron A, Chaudhary MA, Ram M, et al. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS. 2010;24(9):1273–1280.
    1. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E, et al (2011) Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial. AIDS Behav. Mar 19, 2011. doi:10.1007/s10461-011-9927-9.
    1. Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S127–S133.
    1. Simoni JM, Nelson KM, Franks JC, Yard SS, Lehavot K. Are peer interventions for HIV efficacious? A Systematic Review. AIDS Behav. May 20. 2011. doi:10.1007/s10461-011-9963-5.
    1. Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488–495. doi: 10.1037/0278-6133.26.4.488.
    1. Kaponda CP, Norr KF, Crittenden KS, Norr JL, McCreary LL, Kachingwe SI, et al. Outcomes of an HIV prevention peer group intervention for rural adults in Malawi. Health Educ Behav. 2011;38(2):159–170. doi: 10.1177/1090198110378588.
    1. El-Bassel N, Gilbert L, Witte S, Wu E, Hunt T, Remien RH. Couple-based HIV prevention in the United States: advantages, gaps, and future directions. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S98–101.
    1. Wrubel J, Stumbo S, Johnson MO. Male same sex couple dynamics and received social support for HIV medication adherence. J Soc Pers Relat. 2010;27(4):553–572. doi: 10.1177/0265407510364870.
    1. Desgrees-du-Lou A, Orne-Gliemann J. Couple-centred testing and counselling for HIV serodiscordant heterosexual couples in sub-Saharan Africa. Reprod Health Matters. 2008;16(32):151–161. doi: 10.1016/S0968-8080(08)32407-0.
    1. Remien RH, Stirratt MJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19(8):807–814. doi: 10.1097/01.aids.0000168975.44219.45.
    1. El-Bassel N, Witte SS, Gilbert L, Wu E, Chang M, Hill J, et al. The efficacy of a relationship-based HIV/STD prevention program for heterosexual couples. Am J Public Health. 2003;93(6):963–969. doi: 10.2105/AJPH.93.6.963.
    1. El-Bassel N, Witte SS, Gilbert L, Wu E, Chang M, Hill J, et al. Long-term effects of an HIV/STI sexual risk reduction intervention for heterosexual couples. AIDS Behav. 2005;9(1):1–13. doi: 10.1007/s10461-005-1677-0.
    1. Gilbert L, El-Bassel N, Terlikbayeva A, Rozental Y, Chang M, Brisson A, et al. Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot intervention study. J Prev Interv Community. 2010;38(2):162. doi: 10.1080/10852351003640914.
    1. Johnson MO, Dilworth SE, Neilands TB. Partner reports of patients’ HIV treatment adherence. J Acquir Immune Defic Syndr. 2011;56(4):e117–e118. doi: 10.1097/QAI.0b013e31820bd2ce.
    1. Glaser B, Strauss A. Discovery of grounded theory. Chicago: Aldine; 1967.
    1. Strauss A, Corbin J. Basics of qualitative research; techniques adn procedures for developing grounded theory. Thousand Oaks: Sage Publications, Inc.; 1998.
    1. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care. 2000;12(3):255–266. doi: 10.1080/09540120050042891.
    1. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241(4865):540–545. doi: 10.1126/science.3399889.
    1. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204.
    1. Cohen S, Syme SL. Social support and health. Orlando (Florida): Academic Press; 1985.
    1. Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, et al. Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud. 2008;45(12):1757–1763. doi: 10.1016/j.ijnurstu.2008.06.006.
    1. Foster G. Under the radar: community safety nets for AIDS-affected households in sub-Saharan Africa. AIDS Care. 2007;19(Suppl 1):S54–S63. doi: 10.1080/09540120601114469.
    1. Sankar A, Golin C, Simoni JM, Luborsky M, Pearson C. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S54–S68.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner